Epigral Limited (NSE:EPIGRAL)

India · Delayed Price · Currency is INR

990.70

-21.50 (-2.12%)

Oct 9, 2026, 3:29 PM IST

Market Cap	42.99B -41.9%
Revenue (ttm)	26.26B +4.8%
Net Income	2.71B -37.3%
EPS	62.82 -38.1%
Shares Out	43.14M
PE Ratio	15.86
Forward PE	12.40
Dividend	5.00 (0.50%)
Ex-Dividend Date	Jun 1, 2026

Volume	19,948
Open	1,012.20
Previous Close	1,012.20
Day's Range	988.60 - 1,017.90
52-Week Range	807.00 - 1,730.70
Beta	0.31
Analysts	Strong Buy
Price Target	1,728.00 (+74.42%)
Est. Earnings	Oct 27, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharm... [Read more]

Industry Chemicals

Sector Materials

Founded 2007

Employees 1,135

Stock Exchange National Stock Exchange of India

Ticker Symbol EPIGRAL

Full Company Profile

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.27 billion, a decrease of -0.90% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for EPIGRAL stock is "Strong Buy." The 12-month stock price target is ₹1,728, which is an increase of 74.42% from the latest price.

Price Target

₹1,728

(74.42% upside)

Analyst Consensus: Strong Buy

Stock Forecasts